Shenzhen Inovance

Phase A — Understand the business

Lens 1 · Company Overview

Founded 2003 in Shenzhen by 19 former Huawei Electric senior engineers led by Zhu Xingming, and known in-industry as "Little Huawei". IPO'd on the Shenzhen ChiNext in 2010. It is the largest industrial-automation company in China and the country's #2 domestic industrial-robot maker.

How it makes money — four product lines (FY2025 revenue CNY 45.11B, +21.8% YoY):

• Industrial Automation & Digitalization — CNY 22.25B (49.3% of revenue). The core franchise: general-purpose servo systems, low-voltage variable-frequency drives (VFDs/inverters), PLCs, HMIs, motion controllers, industrial robots (SCARA/six-axis), plus the Monarch smart-elevator control business. The "general automation" sub-slice ≈ CNY 16.9B, +23%.
• New-Energy-Vehicle Powertrain — CNY 20.32B (45.1%), +26%. Motor controllers, e-motors, power supplies, and integrated e-drive/e-axle systems. Run through United Power (Suzhou Huichuan United Power, SHE:301656), spun off and separately ChiNext-listed in 2025; Inovance retains 94.5%.
• Emerging Industries — CNY 1.80B (4.0%): industrial robots (as a standalone bucket), rail transit, and energy management / power-conversion systems (PCS).
• Other — CNY 0.74B (1.6%).

Contract structure: components + solutions sold through a direct + distributor model backed by 120+ China service centers and 30+ overseas partners. Not take-or-pay; largely transactional/design-in with long qualification cycles (the switching-cost moat, Lens 3). NEV is design-win-driven, multi-year platform awards to automakers.

Customers: industrial OEMs and end-factories across 30+ verticals (3C electronics, machine tools, textiles, HVAC, lithium/photovoltaic equipment); on the NEV side, Li Auto, Chery, GAC, Xpeng and a broad base of Chinese automakers, plus co-development with American Axle and SKF.

Lens 2 · Supply Chain

Upstream inputs → Inovance → end market:

• Inputs: power semiconductors (IGBTs and increasingly SiC — United Power was among the first Chinese suppliers with an 800V SiC e-drive platform ), MCUs/DSPs, magnets/rare-earths for motors, PCBs, passives, precision machined parts, encoders. Inovance vertically integrates ~42% of BOM in-house by 2024 (chip-level architectures, software stacks, in-house motors) and has localized 70–80% of its supply base within China by late 2025 — a deliberate de-risking against export controls and a cost lever (cited ~15% logistics saving, ~22% lower lead-time variance vs 2022 ).
• Inovance: production hubs at Suzhou (main), Yueyang, Nanjing, Jinan, Jiaxing, Shanghai, plus a Hungary plant for Europe; US R&D center and an Eastern-Europe plant planned; a Japan division under construction. 23,000+ employees.
• Downstream: Chinese factories (automation), Chinese automakers (powertrain), elevator OEMs (Monarch), and — the optionality — humanoid-robot builders as a motor/actuator supplier.

Chokepoints / single-source dependencies: (1) High-end power semis / SiC — a genuine chokepoint; in-house + domestic-fab sourcing mitigates but does not eliminate exposure to US/EU semi export controls. (2) Rare-earth magnets — China-advantaged (a supply-chain strength for a China-based motor maker, the mirror image of Western robotics' rare-earth risk). (3) Foreign high-end PLC IP / dev toolchains — Inovance still trails Siemens TIA Portal / Mitsubishi GX Works in large-PLC software (Lens 3). Names or it didn't happen: the dangerous single-source is itself on the sell side — United Power's fortunes ride on a handful of large NEV OEM accounts (Lens 6: "some key accounts slowing down their pace").

Lens 3 · Competitive Advantages (moats)

Market position (China) — leadership where it counts, weakness at the high end:

• General servo systems: #1, ~26–28.3% share — ahead of Yaskawa and Mitsubishi on home turf.
• Low-voltage VFD/inverter: #1, 22.0% (vs ABB 16.9%, Siemens 15.2%).
• SCARA robots: #1, 27.3% of China units (2024).
• Industrial robots overall: #2 domestic, 8.8% (Estun #1 at 9.5%).
• Small PLC: #4, ~7% — Siemens dominates at 42.3%. This is the moat gap: Inovance itself concedes large-PLC products "require prolonged refinement" and engineers are locked into TIA Portal / GX Works code libraries.

Durable moats:

1. Switching costs / design-in lock-in. Retooling + retraining a line off Inovance's integrated PLC+servo stack runs an estimated $350k–$1.2M per line with weeks of downtime risk. Qualification cycles are long; once standardized, sticky.
2. Vertical integration (~42% BOM in-house) → supplier bargaining power and margin control that pure-assemblers lack.
3. Full-stack one-stop breadth — VFD + servo + PLC + motion + robot + drive under one roof, rare among domestic peers; lets it win on total-solution rather than component price.
4. Localization + cost + speed — the structural China import-substitution tailwind: management explicitly attributes general-automation share gains to taking it from foreign incumbents, not domestic rivals.
5. Talent/culture — the "Little Huawei" R&D machine; R&D at 9.5% of revenue, +36% YoY.

Bargaining power: strong over domestic component suppliers (vertical integration gives internal alternatives); weaker over large NEV OEMs (concentrated, price-punishing buyers) and weaker vs. foreign high-end-PLC/software incumbents where the customer needs them more.

Lens 4 · Segments (revenue trend + cause)

FY2025 main-business composition:

The segment story in one line: the growth mix has flipped — NEV powertrain went from turbocharger to ballast as its price war bites, while general automation is re-accelerating as the "stabilizer". Geographic mix is still ~94% China; overseas ≈ 6.4% of revenue, +39% YoY — small but the fastest-growing slice and the stated strategic priority.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print)

FY2025 (reported 2026-04-28):

• Revenue CNY 45.11B, +21.8% — a beat on the ~CNY 42B early estimate that circulated pre-print.
• Operating profit CNY 5.44B, +17.5%.
• Net profit attributable CNY 5.05B, +17.84% (total net profit CNY 5.17B incl. United Power minority).
• Gross margin 28.95%; net margin 11.47% (−0.27pp). Source conflict, surfaced not resolved: one source reports FY2025 GM 28.95% up +0.25pp YoY; a Morningstar note cites FY2024 GM ~31.5% (vs 36% in 2019) implying multi-year compression. Both can be true if the +0.25pp reflects a stabilization after several years of NEV-driven erosion. Net read: blended GM has structurally compressed toward ~29% as ~45%-of-revenue NEV (mid-20s% GM) diluted the higher-margin automation core.
• ROE ~15.9%, declining. Operating cash flow CNY 6.68B, −7.2% (OCF > net income = clean cash conversion >1x).
• 9M-2025 interim (for cadence): revenue CNY 31.7B (+25%), net profit CNY 4.3B (+27%), GM 29.27% (−1pp), R&D +36% to 9.5% of revenue.

What drove it: general-automation recovery + NEV volume, offset by NEV margin compression — Q3-2025 revenue +21% but net profit +only 4%, explicitly "due to weakness in the automotive business". Balance-sheet flags: none acute; watch receivables/inventory into an NEV price war (Lens 10). Market reaction: the stock de-rated ~30% from its Oct-2025 ATH of CNY 91 to ~CNY 63 even as earnings grew — a classic "good results, worse multiple" as the market prices NEV-margin risk and broad ChiNext weakness.

Lens 6 · Earnings Calls (sentiment trend)

From the Q3-2025 call:

• General Automation = "the stabilizer of our whole group's business"; orders rebounding across 30+ industries; share gains framed as from overseas competitors, not domestic — the import-substitution thesis in management's own words.
• NEV: confident on the 30% annual-growth target but conceding Q3 decel to "some key accounts slowing down their pace" — the customer-concentration tell.
• Humanoid robots: described as potentially "our third king" business — but explicitly core-components-first, not full-robot manufacturing: "Software plus digital platform plus automation software is definitely going to be the definition" of the future.
• Overseas: the biggest strategic drum — "the overall size of the overseas business is two to three times larger than of China and we are still having a very low market share." Target 20–30% of revenue long-term; candid about brand-gap and spec-localization hurdles.
• R&D defended as "a very important driver," +36%.

Tone shift: confident on the structural core (automation "golden track," import substitution, humanoid optionality); noticeably more cautious on near-term NEV pricing and the multi-year slog of overseas execution. The recurring new phrase is "third king" / core-components (humanoid); the thing they've de-emphasized is standalone energy storage ("we're not going to be focusing on energy storage solely" — repositioned to broader smart-energy/PCS).

Lens 7 · Comps

Peer set = global automation majors + China automation/robot-component peers.

The comps read: Inovance at ~25x forward / ~36x trailing is cheaper than Fanuc (42x) and Rockwell (36x fwd) while growing 3–4× faster, and an order of magnitude cheaper than the Chinese robot-component pure-plays (Estun 100x+ on losses; Leaderdrive 600x+ on humanoid mania). It screens as the reasonably-priced way to own the theme — the multiple is a growth-adjusted discount to slow Western incumbents and a deep discount to speculative China robot names.

Lens 8 · Stock-Price Catalysts (>5% moves, ~5yr)

Mostly ``:

• Oct 9, 2025 — all-time high CNY 91.00, on peak NEV+automation momentum and humanoid-supply-chain enthusiasm; 52-week range CNY 55–91.
• 2025 → 2026 de-rate to ~CNY 63 (−~30% from ATH) — NEV margin-compression fears + ChiNext-wide risk-off; share −12.4% YTD, −4.4% LTM (+15% 5yr) as of the ~May-2026 HK filing.
• 2025 — United Power (301656) spin-off/ChiNext IPO — surfaced sum-of-parts value; the NEV arm valued ~CNY 48B, Inovance retains 94.5%.
• Jan–Apr 2026 — Hong Kong IPO announced (Jan) and filed (Apr 28) to raise ~US$2B; A+H internationalization catalyst (Lens 11).
• Recurring pattern: the stock reacts to (1) NEV segment margin/volume prints, (2) humanoid/robotics supply-chain narrative, (3) China industrial-capex cycle, (4) corporate-action liquidity events (United Power, HK listing). It is not primarily an EPS-surprise stock — it trades the mix-and-margin narrative and the theme.

---

Phase C — Judge people & books

Lens 9 · Management

• Zhu Xingming (朱兴明), ~58 — Founder, Chairman & President (CEO). Prior senior roles at Huawei Electric and Emerson Electric before founding Inovance in 2003 with 18 other ex-Huawei engineers. A Forbes-listed billionaire; from Yueyang, Hunan.
• Track record: built the #1 domestic automation franchise from scratch in ~20 years, took share from Siemens/ABB/Yaskawa at home, and stood up a top-tier NEV-powertrain business (United Power: revenue CNY 5.0B→9.4B→16.2B FY2022–24; net profit −180M→186M→936M — turned profitable and scaling). Now orchestrating a triple-listing structure (300124 A-share + United Power 301656 + pending HK) — evidence of sophisticated capital-markets capital allocation.
• Tenure & skin in the game: founder-operator, 20+ years. Control via Shenzhen Inovance Investment founder bloc (~20% voting), Zhu direct ~2.3%, family/daughter ~10% economic; no state golden share — founder-controlled, technically-led.
• Capital allocation: reinvests heavily (R&D 9.5% of revenue), uses carve-out IPOs to crystallize value and fund growth (United Power, HK), modest dividend (~0.9% yield 2026E). Broadly value-creative; ROE mid-teens though declining (~15.9%) as the capital base and lower-margin NEV mix grow.
• Red flags: (1) Founder-linked investment vehicles (Lianyi Chuang, Lianfeng) sit in the United Power cap table — related-party structures to monitor. (2) Multi-entity listing web (parent + sub + HK) raises inter-company-transaction and value-leakage complexity. (3) ISS Governance QualityScore 2 overall but Audit pillar = 8 (elevated-risk decile) as of Jun-2026 — a yellow flag (partly a China-listing/disclosure artifact, but noted).
• Archetype: founder-engineer empire-builder — the right archetype for a still-compounding platform, with the standard founder-control governance caveats.

Lens 10 · Forensic Red Flags

Forensic lens — every figure labeled; web-only, China-GAAP, non-PCAOB audit.

• Revenue recognition / channel risk: the live risk is NEV powertrain into a price war — watch for receivables and inventory outrunning revenue (channel loading to hold volume). Not confirmed in disclosure this pass; flag to verify against the FY2025 20-F-equivalent balance sheet (Chinese annual report) — not sourced at line-item level here.
• Segment reporting: clean and granular in the annual report (four lines with shares); the United Power carve-out improves transparency (its NEV P&L is now separately audited/listed) rather than hiding it.
• Capitalized R&D: with R&D +36% and 9.5% of revenue, capitalized-development-cost accounting is a standard China-tech flatter-of-earnings vector — magnitude not sourced this pass; verify capitalized vs. expensed split.
• Related parties: founder investment vehicles in the sub's cap table (Lens 9) — structural, disclosed, monitor.
• Cash vs. earnings: healthy — OCF CNY 6.68B > net income CNY 5.05B (conversion >1x); the opposite of a classic accrual red flag.
• Minority interest: the CNY ~0.12B gap between total (5.17B) and attributable (5.05B) net profit = United Power's 5.5% minority — mechanical, not a flag.

Regulatory findings (required sub-section):

• SEC (EDGAR): No CIK; Inovance is not an SEC filer — no EDGAR enforcement search possible. regulatory/regulatory-findings.md returns 0 SEC LR/AAER findings (2021-07 → 2026-07) [research file: regulatory/regulatory-findings.md, 2026-07-10].
• Non-SEC / web: No material FTC/DOJ/FDA/consent-decree/fine hits surfaced; Inovance is NOT on the US Commerce Entity List as of this pass — but the Entity List has grown from 1,350 (2019) to ~3,350 (Mar-2025) and a China industrial-tech champion is a structural candidate for future addition (see Lens 13). This is the single most important forward regulatory risk, not a current finding.
• Item-3-equivalent (legal proceedings): no material litigation surfaced in public sources this pass (Chinese-language annual-report legal section not line-item-verified here).
• Net: No material regulatory or legal findings — verified via SEC EDGAR EFTS (0, non-filer), web search, and ISS governance data as of 2026-07-10. Forward tail risk = US Entity-List add; audit-pillar governance score elevated.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (EPS, next 3 FYs — Dec FYE)

Anchor (FY2025 actual): revenue CNY 45.11B; net profit attributable CNY 5.05B; diluted EPS ≈ CNY 1.88. Consensus FY2026E net profit ≈ CNY 6.70B, EPS ≈ CNY 2.489, div yield ~0.9%.

Bottom-up, every line ``:

• Bull: NEV margin bottoms and recovers + humanoid core-components inflects + overseas hits low-teens % of revenue → FY2028 EPS ~CNY 4.0+, and a re-rating to 30–35x on renewed growth confidence.
• Bear: NEV price war deepens (margins to low-20s%) + China industrial capex stalls + overseas stumbles → FY2028 EPS ~CNY 2.6 (growth halves), multiple stays sub-25x.

Base call (for later scoring — NOT logged via forecast.ts per --watchlist rule): 300124.SZ FY2026 net-profit-attributable ≥ CNY 6.5B (p≈0.6), resolves 2027-04-30.

Lens 12 · Bull vs Bear

Bull case. Inovance is the compounding toll-booth on two secular Chinese build-outs at once — factory automation (structural import-substitution from Siemens/ABB/Yaskawa, with Inovance already #1 in servo and LV-VFD) and vehicle electrification (United Power, a scaled, now-profitable top-tier e-drive supplier). Layer on three cheap call options: (1) humanoid core-components — one of few Chinese makers of consistent-quality frameless torque motors, management's stated "third king"; (2) overseas — a TAM management pegs at 2–3× China with "very low" current share, now funded by a ~US$2B HK IPO war chest; (3) PCS/smart-energy targeting global top-3. All of this at ~25x forward, cheaper than slow Western incumbents. Capital allocation is sophisticated (carve-out IPOs crystallize value). Earnings surprise potential: general-automation up-cycle + NEV margin stabilization landing together.

Bear case (permanent-impairment risks). (1) NEV powertrain is a margin trap — 45% of revenue in a Chinese EV price war where OEM customers are concentrated, powerful, and deflationary; United Power's ~6% net margin can be legislated to zero by its own buyers. (2) The high-end software/PLC ceiling — Inovance is stuck at ~7% small-PLC share behind Siemens' 42% and TIA-Portal lock-in; it may be permanently capped below the premium tier where the real margins live. (3) Geopolitical tail — an Entity-List add would sever high-end semiconductor and Western-market access overnight. Pre-mortem (18 months out, thesis broke): the NEV price war didn't stabilize — it accelerated — dragging blended margins below 27%; the automation up-cycle Inovance called a "golden track" fizzled with Chinese industrial capex; and a US tech-restriction headline lopped a fifth off the multiple. Multiples too high? No — ~25x forward is reasonable for 20% growth; the risk is to the E, not the P/E. Contrarian view the market refuses to see: the market is trading this as a humanoid-robot lottery ticket (Emerging = 4% of revenue) when it is really an industrial-automation + EV-powertrain cash machine — so the humanoid narrative is both the thing that over-excites it near ATH and the free option you're not really paying for at CNY 63.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case.

• Structural break in how it makes money: NEV powertrain — nearly half of revenue — is the worst kind of business (concentrated, price-punishing OEM buyers, commodity-drifting e-drives). Chinese automakers are ruthless on cost; a top-3 supplier's "win" can be a margin-losing volume trap. If NEV GM compresses another 300–400bps, group net margin cracks below 11% and the growth story becomes a margins story going the wrong way.
• Revenue concentration: "some key accounts slowing down their pace" is management admitting NEV rides a handful of large OEM programs; a single lost platform (or an OEM in-sourcing e-drive) is a step-down.
• Moat weaker than bulls think: at the high end (large PLC, industrial software) Inovance is a distant #4 and concedes the gap; TIA-Portal/GX-Works lock-in is exactly the moat Inovance itself lacks. Its own moat is strongest in the commoditizing mid-tier where domestic rivals (Estun, Delta) and Chinese newcomers compress price.
• Most dangerous competitor bulls underrate: not Siemens — it's the humanoid OEMs themselves. Unitree, UBTech, and AGIBot are vertically integrating actuators/motors/reducers in-house (Unitree self-develops the actuators that are >50% of a humanoid's cost). Inovance's "third king" component play could be disintermediated before it scales — the customer becomes the competitor.
• Capital-allocation / governance: founder-linked vehicles in the sub cap table; a three-listing web (parent + United Power + HK) that can leak value to minorities and insiders; ISS Audit pillar in the worst decile (8).
• Assumptions that must hold for CNY 63: ~18–20% revenue CAGR, net margin holding ~11–12%, and NEV not deflating further. If growth disappoints 20–30% (say +13% instead of +18% and margins −150bps), FY2027 EPS lands ~CNY 2.4 not ~2.85 and a de-rate to 20x puts the stock in the high-CNY-40s — ~25% downside.
• Single scenario that permanently impairs: US Entity-List addition cutting SiC/high-end-semi supply and Western-market access — plausibility rising but not base case (~15–20% over 3yr).

Lens 14 · Management Questions (15, ordered by information value)

1. What is the through-cycle floor gross margin for NEV powertrain, and at what group-mix does blended net margin stop falling?
2. What share of NEV revenue is the top 3 and top 5 OEM accounts, and how has that concentration moved over two years?
3. For humanoid core components, name the actual design-ins/POs today and the revenue you expect in FY2027 — is this a real order book or a narrative?
4. If your largest humanoid-component customers (Unitree/UBTech-type) in-source actuators, what is your defensible layer?
5. What is the capitalized vs. expensed split of R&D, and how would fully-expensed EPS look?
6. Use of the ~US$2B HK proceeds — specific projects, expected ROIC, and payback?
7. What closes the large-PLC / industrial-software gap to Siemens/Mitsubishi — build, buy, or concede the high end?
8. Overseas: which two regions get to 10%+ share first, on what timeline, and what's the margin there vs. China?
9. Post-United-Power-IPO, how do you prevent value leakage and manage inter-company pricing between parent and sub?
10. What is the plan to arrest the ROE decline (~15.9% and falling) as the capital base grows?
11. Rare-earth and SiC: how self-sufficient are you if export controls tighten on either side?
12. Do you have a contingency if Inovance is added to the US Entity List — supply and market?
13. Elevator (Monarch) is flat amid China property stress — harvest, defend, or exit?
14. What is your buyback/dividend framework as the multi-entity structure generates cash across three listings?
15. Which single business do you expect to be the largest by 2030, and what has to be true?

---